A California company hopes to use stem cell technology developed at the University of Wisconsin-Madison to make new medical and research products.
BioTime, Inc. has signed a licensing agreement with the Wisconsin Alumni Research Foundation to use 173 patents and patent applications covering human embryonic stem cell technology.
The patents cover some of the work of UW-Madison scientist James Thomson.